ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04080	Neuroactive ligand-receptor interaction	18/65	423/7206	1.83743398241e-08
ko04724	Glutamatergic synapse	10/65	152/7206	8.58536521552e-07
ko05030	Cocaine addiction	7/65	73/7206	3.56249053144e-06
ko05033	Nicotine addiction	6/65	56/7206	9.71766996713e-06
ko05031	Amphetamine addiction	7/65	91/7206	1.55805762662e-05
ko04726	Serotonergic synapse	8/65	137/7206	2.81849248012e-05
ko04728	Dopaminergic synapse	8/65	185/7206	0.000234201567471
ko04720	Long-term potentiation	6/65	99/7206	0.000247873073516
ko05034	Alcoholism	9/65	238/7206	0.000255650930319
ko04020	Calcium signaling pathway	9/65	265/7206	0.000563998100768
ko04713	Circadian entrainment	6/65	136/7206	0.00134093476056
ko04730	Long-term depression	4/65	78/7206	0.00521934283221
ko04650	Natural killer cell mediated cytotoxicity	4/65	97/7206	0.0111647189981
ko04014	Ras signaling pathway	7/65	279/7206	0.0123493620383
ko04012	ErbB signaling pathway	4/65	109/7206	0.0165482103315
ko04727	GABAergic synapse	4/65	110/7206	0.0170587447898
ko05032	Morphine addiction	4/65	110/7206	0.0170587447898
ko04360	Axon guidance	6/65	233/7206	0.0180525771325
ko04723	Retrograde endocannabinoid signaling	5/65	175/7206	0.020387128198
ko04540	Gap junction	4/65	128/7206	0.0279704746685
ko05014	Amyotrophic lateral sclerosis (ALS)	3/65	74/7206	0.0288377010392
ko04915	Estrogen signaling pathway	4/65	131/7206	0.030115485587
ko04320	Dorso-ventral axis formation	2/65	31/7206	0.0314946991503
ko04072	Phospholipase D signaling pathway	5/65	197/7206	0.0319278451916
ko05231	Choline metabolism in cancer	4/65	134/7206	0.0323559165548
ko05214	Glioma	3/65	79/7206	0.0340867775372
ko04740	Olfactory transduction	3/65	80/7206	0.0351923661211
ko04015	Rap1 signaling pathway	6/65	278/7206	0.0385222214028
ko04024	cAMP signaling pathway	6/65	279/7206	0.0390974490807
ko04921	Oxytocin signaling pathway	5/65	209/7206	0.0396664101553